mdlinx mdlinx

MDLinx E-mail Article

To email this article, enter your own "From Email" address, the recipient's "To Email" address, and click the "Send Email" button. You may send to up to 5 emails at a time.


* From Email: 
* To Email: 
To Email: 
To Email: 
To Email: 
To Email: 
Email Subject Line: 
Comments:

Markers of the APC/beta-catenin signaling pathway as potential treatable, pre-neoplastic biomarkers of risk for colorectal neoplasms

Ahearn TU et al. – These preliminary data suggest that the combined expression of APC and beta-catenin in the normal rectal mucosa may be associated with risk for incident, sporadic colorectal neoplasms, as well as with modifiable risk factors for colorectal neoplasms. Our results may help advance the development of treatable, pre-neoplastic biomarkers of risk for colorectal neoplasms

Methods

  • We evaluated APC, beta-catenin, and E-cadherin expression in normal mucosa from the rectum and ascending and sigmoid colon using automated immunohistochemistry and quantitative image analysis.
  • Diet, lifestyle, and medical history were assessed with validated questionnaires.

Results
  • In the normal rectal mucosa, the ratio of the proportion of APC expression in the upper 40% of crypts with total ?-catenin expression (APC/beta-catenin score) was 14.3% greater in controls than in cases (p=0.02) (odds ratio [OR] 0.40, 95% confidence interval [CI] 0.14 - 1.14).
  • Compared to controls, in cases, APC expression was 3.2% lower, ?-catenin expression was 3.0% higher, and E-cadherin expression was 0.7% lower; however, none of these differences was statistically significant.
  • The APC/?-catenin score statistically significantly differed according to categories of plausible risk factors for colorectal cancer (e.g., it was 17.7% higher among those with 25[OH]-vitamin D3 concentrations >/= 27 ng/ml).
[more...]

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close